LGC acquires antigens and antibodies company NAC

By LabPulse.com staff writers

July 9, 2020 -- Life sciences company LGC has acquired the Native Antigen Company (NAC), an Oxford, U.K.-based supplier of infectious disease antigens and antibodies.

NAC's portfolio includes 60 viral and infectious disease products, including pathogen receptors, virus-like particles and antibodies for immunoassay technologies, and vaccine development and quality control solutions. The global supplier also offers antigens for SARS-CoV-2 to help researchers respond to the COVID-19 pandemic.

The acquisition will bolster LGC's product offerings in the IVD market, according to the company. LGC's existing IVD offerings include quality assurance tools, immunoassay reagents, disease-state plasma, and probes and primers for molecular diagnostics.

Scientists urge surveillance of new SARS-CoV-2 variant
A SARS-CoV-2 variant carrying an amino acid change -- D614G -- in the spike protein has become the predominant form of the virus in the current global...
Physicians criticize U.K. antibody testing strategy
Medical and public health experts from the U.K. and Switzerland have come out against the quick rollout of COVID-19 antibody testing in England. The group...
FDA airs antibody test performance specs, educational video
The U.S. Food and Drug Administration (FDA) has published detailed performance specifications for four more commercial antibody tests. Separately, the...
What we know about SARS-CoV-2 immunity so far
U.K. virologists have reviewed over 40 studies on SARS-CoV-2 immunity and discussed how this current knowledge about immune responses can inform virus...
FDA pulls plug on wayward coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) has published the names of 28 coronavirus antibody tests that may no longer be marketed or distributed, as...

Copyright © 2020 LabPulse.com

Last Updated ls 7/10/2020 9:32:04 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current